Effect of Glycopyrronium on QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study

Trial Profile

Effect of Glycopyrronium on QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Oct 2013

At a glance

  • Drugs Glycopyrrolate (Primary) ; Moxifloxacin
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Oct 2013 New trial record
    • 13 Sep 2013 Primary endpoint 'QT-interval' has been met.
    • 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top